Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1434)
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
3,277
Price
$1.93
Total Value
$6.32K
Shares Held After
16,689
% of Holdings
19.6%
BioAge Labs, Inc. (BIOA)
Barton Shane — Principal Accounting Officer
Shares
20,216
Price
$25.19
Total Value
$509.18K
Shares Held After
0
% of Holdings
100.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
7,026
Price
$18.53
Total Value
$130.22K
Shares Held After
1,203,784
% of Holdings
0.6%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
2,106
Price
$1.93
Total Value
$4.06K
Shares Held After
13,113
% of Holdings
16.1%
X4 Pharmaceuticals, Inc (XFOR)
KIRSKE DAVID — Chief Financial Officer
Shares
8,543
Price
$4.26
Total Value
$36.43K
Shares Held After
167,750
% of Holdings
4.8%
Nuvectis Pharma, Inc. (NVCT)
Mosseri Marlio Charles — 10% Owner
Shares
50,000
Price
$18.32
Total Value
$916.00K
Shares Held After
3,186,576
% of Holdings
1.6%
Nuvectis Pharma, Inc. (NVCT)
BENTSUR RON — Director
Shares
12,500
Price
$20.00
Total Value
$250.00K
Shares Held After
3,688,424
% of Holdings
0.3%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
20,000
Price
$12.00
Total Value
$240.04K
Shares Held After
90,180
% of Holdings
18.2%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
200,000
Price
$35.45
Total Value
$7.09M
Shares Held After
1,748,403
% of Holdings
10.3%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
17,000
Price
$26.82
Total Value
$455.90K
Shares Held After
614,321
% of Holdings
2.7%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
58,000
Price
$25.94
Total Value
$1.50M
Shares Held After
631,321
% of Holdings
8.4%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
7,400
Price
$3.03
Total Value
$22.42K
Shares Held After
98,589
% of Holdings
7.0%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
831
Price
$23.34
Total Value
$19.40K
Shares Held After
33,885
% of Holdings
2.5%
REGENXBIO Inc. (RGNX)
PAKOLA STEVE — Chief Medical Officer
Shares
19,608
Price
$11.04
Total Value
$216.47K
Shares Held After
213,009
% of Holdings
8.4%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
273,871
Price
$17.23
Total Value
$4.72M
Shares Held After
9,237,279
% of Holdings
2.9%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
6,997
Price
$35.05
Total Value
$245.23K
Shares Held After
124,672
% of Holdings
5.3%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
8,300
Price
$35.05
Total Value
$290.91K
Shares Held After
58,750
% of Holdings
12.4%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
2,300
Price
$35.12
Total Value
$80.79K
Shares Held After
56,450
% of Holdings
3.9%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
6,888
Price
$35.05
Total Value
$241.45K
Shares Held After
345,879
% of Holdings
2.0%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
2,748
Price
$34.71
Total Value
$95.38K
Shares Held After
16,474
% of Holdings
14.3%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
15,002
Price
$34.32
Total Value
$514.87K
Shares Held After
19,222
% of Holdings
43.8%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
42,924
Price
$5.85
Total Value
$251.11K
Shares Held After
497,751
% of Holdings
7.9%
PRECIGEN, INC. (PGEN)
Sabzevari Helen — President and CEO
Shares
346,836
Price
$5.89
Total Value
$2.04M
Shares Held After
3,768,872
% of Holdings
8.4%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
881
Price
$192.61
Total Value
$169.69K
Shares Held After
21,656
% of Holdings
3.9%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
541
Price
$191.87
Total Value
$103.80K
Shares Held After
22,537
% of Holdings
2.3%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
600
Price
$190.54
Total Value
$114.33K
Shares Held After
23,078
% of Holdings
2.5%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
100
Price
$188.57
Total Value
$18.86K
Shares Held After
23,678
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
300
Price
$187.83
Total Value
$56.35K
Shares Held After
23,778
% of Holdings
1.2%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
858
Price
$186.92
Total Value
$160.37K
Shares Held After
24,078
% of Holdings
3.4%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
1,100
Price
$185.90
Total Value
$204.49K
Shares Held After
24,936
% of Holdings
4.2%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
900
Price
$184.59
Total Value
$166.13K
Shares Held After
26,036
% of Holdings
3.3%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
300
Price
$183.17
Total Value
$54.95K
Shares Held After
26,936
% of Holdings
1.1%
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
28,571
Price
$5.78
Total Value
$165.14K
Shares Held After
525,964
% of Holdings
5.2%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
11,579
Price
$35.91
Total Value
$415.82K
Shares Held After
1,047,205
% of Holdings
1.1%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
13,421
Price
$35.13
Total Value
$471.53K
Shares Held After
1,058,784
% of Holdings
1.3%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
876
Price
$40.34
Total Value
$35.34K
Shares Held After
548,027
% of Holdings
0.2%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
7,344
Price
$39.77
Total Value
$292.06K
Shares Held After
548,903
% of Holdings
1.3%
ImmunityBio, Inc. (IBRX)
Selecky Christobel — Director
Shares
95,722
Price
$9.01
Total Value
$862.22K
Shares Held After
0
% of Holdings
100.0%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
5,500
Price
$123.51
Total Value
$679.30K
Shares Held After
58,117
% of Holdings
8.6%
Akebia Therapeutics, Inc. (AKBA)
Ostrowski Erik — SVP, CFO, CBO & Treasurer
Shares
56,019
Price
$1.11
Total Value
$62.18K
Shares Held After
616,616
% of Holdings
8.3%
Candel Therapeutics, Inc. (CADL)
Tyagarajan Seshu — Chief Technology Officer
Shares
7,000
Price
$10.02
Total Value
$70.15K
Shares Held After
83,865
% of Holdings
7.7%
Candel Therapeutics, Inc. (CADL)
Barone Francesca — Chief Scientific Officer
Shares
23,447
Price
$10.06
Total Value
$235.77K
Shares Held After
77,362
% of Holdings
23.3%
Protara Therapeutics, Inc. (TARA)
Shefferman Jesse — Director
Shares
215,687
Price
$4.09
Total Value
$882.16K
Shares Held After
721,832
% of Holdings
23.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$28.02
Total Value
$210.15K
Shares Held After
26,250
% of Holdings
22.2%
BioAge Labs, Inc. (BIOA)
Barton Shane — Principal Accounting Officer
Shares
42,350
Price
$25.21
Total Value
$1.07M
Shares Held After
0
% of Holdings
100.0%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
25,000
Price
$2.60
Total Value
$65.00K
Shares Held After
373,322
% of Holdings
6.7%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Showing 51–100 of 1434 transactions (page 2 of 29)